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Antimicrobial activity, chemical composition and
cytotoxicity of Lentinus crinitus basidiocarp
Míria Benetati Delgado Bertéli, a Lillian Barros, b Filipa S. Reis,b
Isabel C. F. R. Ferreira, b Jasmina Glamočlija, c Marina Soković, c
Juliana Silveira do Valle,a Giani Andrea Linde, a Suelen Pereira Ruiza and
Nelson Barros Colauto *a
Lentinus crinitus (L.) Fr. (Basidiomycota: Polyporales) is a wild mushroom with several biotechnological
applications; however, there are few studies on its chemical composition and antimicrobial activity.
Therefore, this study aims to evaluate the chemical composition, cytotoxicity, and antimicrobial activity of
L. crinitus basidiocarp. For that, its nutritional value (AOAC procedures) and its composition in some
hydrophilic and lipophilic compounds (chromatographic techniques) were assessed. Moreover, the
potential hepatotoxic effects were evaluated using a primary cell culture obtained from porcine liver, and
its growth inhibitory capacity was also evaluated against four human tumour cell lines (spectrophoto-
metric assays). The antimicrobial activity was evaluated by microdilution against eight bacteria and fungi.
The basidiocarp has a high content of carbohydrates and, therefore, a relatively high energetic value. It is
also rich in soluble sugars, β-tocopherol, phenolic acids, mainly p-hydroxybenzoic acid, and organic
acids, mainly malic acid. L. crinitus did not show cytotoxicity in non-tumour cells, but it did not inhibit the
growth of human tumour cell lines either. The basidiocarp has a wide antimicrobial activity, inhibiting the
growth of different species of bacteria and fungi. It showed minimum bactericidal and fungicidal concen-
tration values similar to or lower than those verified by commercial antibiotics or food additives used as
preservatives. The antimicrobial activity was more evident against Listeria monocytogenes, Salmonella
enterica, and Penicillium ochrochloron, followed by Aspergillus ochraceus and Trichoderma viride, when
compared to the controls. The results obtained in this study showed that L. crinitus basidiocarp has great
potential to be used by the industry without toxicity risks.
1. Introduction
Basidiomycota represents the second largest phylum of the
kingdom fungi with more than 30 000 identified species1 and
is one of the greatest unexploited resources of natural com-
pounds.2 Edible mushrooms are highly nutritional and
healthy3 with reported bioactivities such as antitumoral,
immunostimulant, antioxidant, antimicrobial, hypocholestero-
lemic, and hepatoprotector activities, among others.4–6
Lentinus crinitus (L.) Fr. (Basidiomycota: Polyporales) is a
pantropical and neotropical7 mushroom commonly found in
decomposing tree trunks.8 The basidiocarps are consumed as
a source of protein by indigenous people from Yanomami and
Txicão tribes in Brazil, Uitoto, Muinane, and Andoke in
Colombia, Hotï in Venezuela, and the rural population of
Loreto in Peru.9 There are some reports on its antioxidant
potential,10 metal bioaccumulation capacity,11,12 and high
enzyme production capacity (i.e. laccase,13 protease,14 and
xylanase15). We can find some studies regarding the nutri-
tional potential of this mushroom, namely its content in
ashes, fat, protein, and total carbohydrates.16–18 To the best of
our knowledge, the antimicrobial potential of L. crinitus basi-
diocarp has been reported just against Fusarium sp. conidium
sporulation.19 However, there are no detailed reports on its
chemical characterization, cytotoxicity, or antimicrobial
activity against foodborne pathogens.
Foodborne diseases are one of the major burdens to public
health, caused by the consumption of contaminated foods
with pathogenic microorganisms or their toxins.20,21 The main
contaminants of food are bacteria20 and mycotoxins, resulting
in average costs of 100 billion dollars per year for developing
countries.22 Some of these pathogenic microorganisms
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include Pseudomonas aeruginosa, a multi-drug resistant bacter-
ium,23 Listeria monocytogenes, which develops multidrug resis-
tance,24 and Bacillus cereus which causes food intoxication.25
Therefore, these are relevant bacteria that cause foodborne dis-
eases to be controlled with new compounds. Several synthetic
chemical compounds, such as nitrates, benzoates, sulfites,
and sorbates are applicable to foods for their preservation.
However, some of these compounds have been related to unde-
sirable effects on human health such as allergies or even carci-
nogenic effects.21,26,27 Thus, the search for natural compounds
as an alternative for food preservation has been one of the
fields of interest of scientific research in recent years. Thus,
this study aimed to evaluate the chemical composition, cyto-
toxicity, and antimicrobial activity of L. crinitus basidiocarp
grown on agro-industrial residues, contributing to the food
science and technology field.
2. Materials and methods
2.1 Biological material
This study used Lentinus crinitus (L.) Fr. (Basidiomycota:
Polyporales) U9-1 strain from the Culture Collection of the
Laboratory of Molecular Biology at Paranaense University, cryo-
preserved by the wheat grain technique,28,29 identified by
sequencing the internal transcribed spacers (ITS) of ribosomal
DNA, and deposited in the GenBank database (http://www.
ncbi.nlm.nih.gov/genbank/) with the accession number
MG211674.29 The strain was registered in the National System
of Genetic Patrimony Management and Associated Traditional
Knowledge (SisGen, its acronym in Portuguese) under the code
A04E776. The fungus was cultivated in a 2% malt extract agar
(MEA) substrate at 25 ± 1 °C for seven days, and the colonies
without sectioning and with mycelial growth vigor were
selected as the inoculum of wheat grains. Wheat grains cooked
at 90 °C in ultrapure water for 40 min were used. After
cooking, the excess water was removed and 1 g of calcium car-
bonate (CaCO3) was added to every 100 g of grains. The grains
were transferred to polypropylene bags and autoclaved at
121 °C for 1 h and 30 min. After cooling, MEA disks containing
mycelia were transferred to the bags with grains and incubated
at 25 ± 1 °C until complete colonization.30 The colonized
wheat grains were utilized as inoculum on the cultivation
substrate.
2.2 Cultivation substrate for mushroom production
Sugarcane bagasse and rice husks from a sugarcane processing
mill and from a rice mill, respectively, were utilized with a 1 : 1
(v : v) proportion to compose the cultivation substrate with 10
replications. Each replication was represented by a polypropyl-
ene bag with 2 kg of the cultivation substrate autoclaved for
1 h and 30 min at 121 °C. To each bag was added 20 g of
wheat grains containing fungus, thermosealed, and stored in a
cultivation room with temperature control at 27 ± 1 °C and
80% air humidity until complete substrate colonization. After
30 days, the top part of the bags was opened, and room temp-
erature was reduced to 18 ± 1 °C for 24 h (thermal shock). The
basidiocarp harvesting was performed daily when the pileus
edge was flat, indicating growth completion and senescence
process onset. The harvested basidiocarps (stipe and pileus
together) were dehydrated in an air circulating oven at 60 °C
for 24 h, ground in a mortar with a pestle to obtain granulome-
try ≤0.35 mm (48 mesh) and stored at −20 °C for subsequent
analyses.
2.3 Chemical composition of the basidiocarp
2.3.1 Macronutrient composition and energetic value. The
proximate composition (protein, fat, ash, and carbohydrate
content) of the samples was determined according to standard
procedures.31 The crude protein content (N × 4.38) of the
samples was estimated by the macro-Kjeldahl method; crude
fat was determined by extracting a known mass of the pow-
dered sample with petroleum ether, using a Soxhlet apparatus;
the ash content was determined by incineration at 600 ± 15 °C.
Total carbohydrates were calculated by difference [total carbo-
hydrates (g per 100 g; dry basis) = 100 − (gprotein + gfat + gash)].
The energy was calculated according to Regulation (EC)
number 1169/2011 of the European Parliament and of the
Council32 on the Provision of Food Information to Consumers,
as: energy [(kcal per 100 g; dry basis) = 4 × (gprotein + gcarbohy-
drates) + 9 × (gfat)].
2.3.2 Hydrophilic compounds
Soluble sugars. The dried samples (1 g) were spiked with
raffinose as the internal standard (IS, 25 mg mL−1) and
extracted with 40 mL of 80% aqueous ethanol at 80 °C for 1 h.
The resulting suspension was centrifuged (15 000g for 10 min).
The resulting suspension was filtered and concentrated under
reduced pressure (rotary evaporator Büchi R-210, Flawil,
Switzerland) and defatted three times with 10 mL of diethyl
ether. After concentration at ≈40 °C, the solid residues were
dissolved in water to a final volume of 5 mL and filtered
through 0.2 μm disposable LC nylon disk filters and trans-
ferred into an injection vial to be analyzed by high perform-
ance liquid chromatography (HPLC). The soluble sugars
present in L. crinitus basidiocarp were analyzed by HPLC using
a refraction index (RI) detector. The HPLC equipment con-
sisted of an integrated system with a pump (Knauer, Smartline
system 1000, Berlin, Germany), degasser system (Smartline
manager 5000), autosampler (AS-2057 Jasco, Easton, MD, USA)
and an RI detector (Knauer Smartline 2300). Data were ana-
lyzed using Clarity 2.4 software (DataApex). The chromato-
graphic separation was achieved with a Eurospher 100-5 NH2
column (4.6 × 250 mm, 5 mm, Knauer) operating at 30 °C
(7971 R Grace oven). The mobile phase was acetonitrile :
deionized water, 70 : 30 (v : v) at a flow rate of 1 mL min−1. The
compounds were identified by chromatographic comparisons
with authentic standards. The quantification was performed
using the internal standard method.33 The results were
expressed in g per 100 g (dry basis).
Organic acids. Samples (approximately 1.5 g) were extracted
using 25 mL of meta-phosphoric acid (25 °C at 150 rpm) by
stirring for 45 min and subsequently filtered through filter
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paper (Whatman® grade 4). Before analysis, the sample was
filtered through 0.2 μm nylon filters.34 The organic acid profile
of the studied samples was determined according to a pre-
viously described procedure.34 The analysis was performed by
ultra-fast liquid chromatography (UFLC), coupled to a photo-
diode array detector (PDA), following the previously mentioned
procedure. The analysis was performed using a Shimadzu 20A
series UFLC (Shimadzu Corporation, Kyoto, Japan). Separation
was achieved on a SphereClone (Phenomenex, Torrance, CA,
USA) reverse phase C18 column (5 µm, 250 mm, 4.6 mm i.d.)
thermostatted at 35 °C. The elution was performed with sulfu-
ric acid (3.6 mM) using a flow rate of 0.8 mL min−1. Detection
was carried out in a PDA, using 215 nm and 245 nm (for
ascorbic acid) as preferred wavelengths. The found organic
acids were quantified by comparing the area of their peaks
recorded at 215 nm (245 nm for ascorbic acid) to calibration
curves obtained from commercial standards of each com-
pound. The results were expressed in mg per 100 g (dry basis).
Phenolic acids and related compounds. The dried samples
(approximately 1 g) were extracted using 30 mL of aqueous
methanol (80 : 20; v : v) by magnetic stirring (25 °C, 150 rpm)
for 1 h, and subsequently filtered (Whatman® grade 4 filter
paper) obtaining a hydromethanolic extract. The extraction
procedure was repeated with an additional portion of the
solvent, repeating the previous process. The obtained extracts
were combined, the methanol was evaporated (rotary evapor-
ator previously referred) and the residual aqueous phase was
frozen and lyophilized.35 After lyophilization, the dried extract
was dissolved in aqueous methanol (20 : 80; v : v) obtaining a
20 mg mL−1 final concentration, filtered through a 0.2 μm
nylon filter and analyzed by UFLC. The phenolic acid determi-
nation was performed using the UFLC system mentioned
before for organic acid determinations. Detection was carried
out in the PDA (photodiode-array detection), using 280 nm as
the preferred wavelength and in a mass spectrometer (MS) con-
nected to a HPLC system via the PDA cell outlet. The phenolic
compounds were identified by comparing their retention
times, UV-Vis and mass spectra with those obtained with stan-
dard compounds. For the quantitative analysis, a calibration
curve for each available phenolic standard was constructed
based on the UV-Vis signal. The results were expressed as µg
per 100 g (dry basis).
2.3.3 Lipophilic compounds
Fatty acids. Fatty acids (obtained after Soxhlet extraction)
were methylated with 5 mL of methanol : 95% sulfuric acid :
toluene (2 : 1 : 1; v : v : v) for approximately 12 h in a bath at
50 °C and 160 rpm; to obtain phase separation, 3 mL of de-
ionized water were added; the fatty acid methyl esters (FAME)
were recovered by shaking in a vortex with 3 mL of diethyl
ether, and the upper phase was passed through a micro-
column of anhydrous sodium sulfate to eliminate water. The
sample was recovered in a vial with Teflon and filtered through
a 0.2 µm Whatman® nylon filter.36 The fatty acid profile of the
samples was determined by gas–liquid chromatography with a
flame ionization detection (GC-FID)-capillary column. The
identification of the different fatty acids was made by compari-
son of the relative retention time of FAME peaks from samples
with standards. The results were expressed in the relative per-
centage of each fatty acid.
Tocopherols. Extracts were prepared following a previously
described procedure.37 Before extraction, samples were added
with butylhydroxytoluene (BHT, 100 μL) and spiked with tocol
(250 μL) as the internal standard (IS) for further chromato-
graphic analysis. Samples (≈500 mg) were extracted by vortex
mixing with methanol (4 mL) for 1 min; subsequently, hexane
(4 mL) was added and the mixture was vortexed again for one
additional minute. Finally, a saturated NaCl aqueous solution
(2 mL) was added and the mixture was homogenized (1 min).
After that, samples were centrifuged (5 min, 4000g), and the
upper layer, corresponding to the hexane fraction, was trans-
ferred to a 25 mL amber vial. Samples were re-extracted twice
with hexane and the combined extracts were dehydrated with
anhydrous sodium sulfate, taken to dryness under a nitrogen
stream and stored at −20 °C. Tocopherol extracts were re-dis-
solved in 1 mL of n-hexane, filtered (0.22 μm disposable LC
filter disk), and transferred to an amber injection vial for chro-
matographic analysis. The analysis was performed using the
same HPLC system described for soluble sugars but coupled
to a fluorescence detector. The tocopherol identification was
performed by chromatographic comparisons with authentic
standards and the quantification was based on the fluo-
rescence signal response of each standard. The results were
expressed in µg per 100 g (dry basis).
2.4 Biological activities of the basidiocarp
2.4.1 Extract preparation. The same extraction procedure
described for the phenolic compounds was applied for the
cytotoxicity and antimicrobial activity assays. After the lyophili-
zation process, the obtained extracts were re-dissolved in: (i)
autoclaved distilled water, at 8 mg mL−1, to assess the cytotoxic
activity assay; and (ii) 5 mL per 100 mL solution of DMSO in
distilled water, at 100 mg mL−1, to assess the antimicrobial
activity assay. These solutions were diluted successively in
order to obtain the concentrations necessary to perform the
experimental study.
2.4.2 Cytotoxic activity. Four human tumor cell lines were
used, namely HeLa (cervical carcinoma), HepG2 (hepatocellu-
lar carcinoma), MCF-7 (breast adenocarcinoma), and
NCI-H460 (non-small cell lung cancer). Cells were routinely
maintained as adherent cell cultures and treated for 48 h with
the diluted extract solutions.38 The adherent cells were fixed
by adding cold 10% trichloroacetic acid (TCA, 100 mL) and
incubated for 60 min at 4 °C. Plates were then washed with de-
ionized water and dried; 0.1% sulforhodamine B solution
(SRB, 100 mL) in 1% acetic acid was then added to each plate
well and incubated for 30 min at room temperature. Unbound
SRB was removed by washing with 1% acetic acid. Plates were
air-dried, the bound SRB was solubilized with 10 mM tris
(200 mL, pH 7.4) and the absorbance was measured at
540 nm. The results were expressed as GI50 values (sample con-
centration that inhibited 50% of the net cell growth).
Ellipticine was used as a positive control. For the possible
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hepatotoxicity evaluation, a culture cell obtained from porcine
liver, designed as PLP2, was used.39 The same procedure
described above for the SRB assay was performed for the
growth inhibition. The results were also expressed as GI50
values.
2.4.3 Antibacterial activity. The antibacterial activity of
L. crinitus basidiocarp extract was tested against the following
Gram-positive bacteria: Staphylococcus aureus subsp. aureus
Rosenbach (ATCC 6538), Bacillus cereus Frankland and
Frankland (clinical isolate), Micrococcus luteus (Schroeter)
Cohn (ATCC 10240), and Listeria monocytogenes (Murray et al.)
Pirie (NCTC 7973), and the following Gram-negative ones:
Pseudomonas aeruginosa (Schroeter) Migula (ATCC 27853),
Escherichia coli (Migula) Castellani and Chalmers (ATCC
35218), Enterobacter cloacae (Jordan) Hormaeche and Edwards
(clinical isolate), and Salmonella enterica subsp. enterica (ex-
Kauffmann and Edwards) Le Minor and Popoff serovar
Typhimurium (ATCC 13311). The broth microdilution method
in 96-well microtiter plates was used.40,41 The bacterial suspen-
sions were standardized with sterile saline solution (0.85%)
until the concentration of 1.0 × 105 CFU mL−1. The prepared
inoculums were stored at 4 °C until their utilization. The
extract was dissolved in DMSO solution (50 mL L−1) containing
1 mg mL−1 polysorbate-80 and added to the wells containing
100 µL of LB (Luria Bertani) cultivation medium according to
Miller.42 Next, the bacterial suspensions at 1.0 × 105 CFU mL−1
were added until reaching the desired concentrations. The
mixtures were deposited in microplates and incubated in a
rotary agitator (160 rpm) for 24 h at 37 °C. The lowest concen-
trations of the extract that were able to completely inhibit bac-
terial growth, without visible growth in an optical microscope,
were defined as the minimum inhibitory concentrations
(MIC). The minimum bactericidal concentration (MBC) was
determined by serial sub cultivation in microtiter plates con-
taining 100 µL of LB broth41 per well and incubated for 24 h.
The lowest concentration without bacterial growth was defined
as MBC, indicating 99.5% death of the original inoculum. The
optical density of each well was measured at a wavelength of
655 nm using Microplate Manager 4.0 (Bio-Rad Laboratories)
and compared to the blank and the positive control. The anti-
biotics streptomycin (Sigma P 7794) and ampicillin (Panfarma)
(1 mg mL−1 in sterile saline solution) and the food additives
sodium sulfite (E221) and potassium metabisulfite (E224)43
from 0.001 to 3.5 mg mL−1 were used as positive controls, and
DMSO solution (50 mL L−1) was used as the negative control.
2.4.4 Antifungal activity. The antifungal activity of the basi-
diocarp extract was evaluated in eight fungi: Aspergillus fumiga-
tus Fresenius (ATCC 1022), Aspergillus niger van Tieghem
(ATCC 6275), Aspergillus ochraceus Batista et Maia (ATCC
12066), Aspergillus versicolor (Vuillemin) Tiraboschi (ATCC
11730), Penicillium funiculosum Thom (ATCC 8725), Penicillium
ochrochloron Biourge (ATCC 90288), Penicillium verrucosum var.
cyclopium (Westling) Samson, Stolk & Hadlok (food isolate),
and Trichoderma viride Pers. (IAM 5061). The microorganisms
were kept in 2% malt agar at 4 °C.44 The modified microdilu-
tion technique using 96-well microtiter plates was used to
assess the antifungal activity of the basidiocarp extract.40,41
The fungal spores were washed from the plate surface with a
sterile 0.85% saline solution containing 1 mg mL−1 polysor-
bate-80. The spore suspension was adjusted with saline solu-
tion (0.85%) until approximately 1.0 × 105 conidia per mL for
the final volume of 100 μL per well and stored at 4 °C until
use. The diluted inoculums were cultivated in 2% malt extract
agar to prove the absence of contamination. The basidiocarp
extract was diluted in DMSO solution (50 mL L−1) containing
1 mg mL−1 polysorbate-80. Each solution with the diluted
extract was added to 2% malt extract medium containing
inoculum. The microplates were incubated in a rotary agitator
(160 rpm) for 72 h at 28 °C. The wells with the lowest concen-
trations of visible extract without growth, but visible under an
optical microscope, were defined as the minimum inhibitory
concentration (MIC) of the extract. The minimum fungicidal
concentration (MFC) was determined by a serial sub cultiva-
tion of 2 μL of evaluated fungal cultures which were dissolved
in culture medium and inoculated in microtiter plates contain-
ing 100 μL of 2% malt extract broth per well for 72 h at 28 °C.
The lowest concentration without visible growth under an
optical microscope was defined as the MFC, indicating 99.5%
of the original inoculum death. The commercial fungicides
bifonazole (Srbolek) and ketoconazole (Zorkapharma, Šabac,
Serbia) and the food additives sodium sulfite (E221) and pot-
assium metabisulfite (E224)43 from 0.001 to 3.5 mg mL−1 were
used as positive controls, and DMSO solution (50 mL L−1) was
used as the negative control.
2.5 Experimental design and statistical analysis
For chemical, cytotoxic, and antimicrobial analyses, three ran-
domly chosen samples were used, and all assays were carried
out in triplicate. The results were expressed as arithmetical
average ± standard deviation (SD) and an analysis of variance
(ANOVA) was applied, and the typical requirements, homosce-
dasticity by Levene’s test and normal distribution by Shapiro
Wilk’s test, were preliminarily performed. Welch test was
applied to verify the existence of statistically significant differ-
ences. The ANOVA results were classified using Tukey HSD
(honestly significant difference) test or Tamhane’s T2, when
homoscedasticity was verified, respectively. All statistical tests
were performed at a 5% significance level using IBM SPSS
Statistics for Windows, version 25 (IBM Corporation,
New York, USA).
3. Results
Regarding the proximate composition, carbohydrates were the
most abundant macronutrient compound present in L. crinitus
basidiocarp (82.4 g per 100 g), followed by proteins (13.0 g per
100 g). Ashes and total fat were part of the minority com-
pounds, obtaining an energy value of 385.4 kcal per 100 g
(Table 1).
Regarding the hydrophilic compounds found in the basi-
diocarp, the main soluble sugar was trehalose (80%), followed
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by sucrose (16%) and mannitol (4%) (Table 2). The main
organic acids were malic acid (84%), followed by oxalic acid
(15%) and fumaric acid (<1%) (Table 2). The main phenolic
acid found was p-hydroxybenzoic acid and a precursor of
complex phenolic compounds, cinnamic acid (Table 2).
Regarding the lipophilic compounds of the basidiocarp,
polyunsaturated fatty acids (PUFA) were the major ones over
saturated fatty acids (SFA) and monounsaturated fatty acids
(MUFA) (Table 3). Twenty fatty acids were identified in the
lipid fraction of the basidiocarp and the major chemical com-
pounds were linoleic (66.4%), palmitic (11.2%), and oleic
(9.8%) acids (Table 3). Also, β-tocopherol was identified in the
basidiocarp at 505 µg per 100 g (Table 3).
The basidiocarp extracts did not show cytotoxicity, since
there was no growth inhibition of tumor and non-tumor cell
cultures at the tested concentrations (GI50 values higher than
400 µg mL−1; Table 4). These results indicate that L. crinitus is
safe for human consumption although, as previously men-
tioned, it is mostly consumed by Amazonian Indians.9,45
The basidiocarp extract of L. crinitus presented bacterio-
static activity against all evaluated bacterial strains. The MIC
values for the basidiocarp extract ranged from 0.12 to
0.499 mg mL−1. For the positive controls, they ranged from
0.040 to 0.248 mg mL−1 for streptomycin and from 0.25 to
0.74 mg mL−1 for ampicillin. Regarding the commercial addi-
tives used, MIC values ranged from 1.00 to 3.97 mg mL−1 for
E221 and from 0.505 to 2.01 mg mL−1 for E224 (Fig. 1). The
basidiocarp extract MIC values were all equal to or lower than
the food additive controls (Fig. 1). Only for E. coli the value
obtained for the basidiocarp extract was equal to that of E224
Table 1 Macronutrient composition and energetic value of dried
Lentinus crinitus basidiocarp
Nutrient/energy Value
Ash (g per 100 g) 4.2 ± 0.2
Proteins (g per 100 g) 13.0 ± 0.7
Fat (g per 100 g) 0.48 ± 0.03
Carbohydrates (g per 100 g) 82.4 ± 0.4
Energy (kcal per 100 g) 385.4 ± 0.8
Values expressed as arithmetic mean ± standard deviation (dry basis;
n = 3).
Table 2 Chemical composition of the hydrophilic extract (sugars,
organic acids, and phenolic acids) of Lentinus crinitus basidiocarp
Compound Value
Sugar (g per 100 g)
Mannitol 0.18 ± 0.01
Sucrose 0.73 ± 0.05
Trehalose 3.5 ± 0.2
Total soluble sugars 4.4 ± 0.3
Organic acids (mg per 100 g)
Oxalic acid 132 ± 5
Malic acid 730 ± 4
Fumaric acid 0.035 ± 0.001
Total organic acids 863 ± 1
Phenolic acids (µg per 100 g)
p-Hydroxybenzoic acid 724 ± 12
Cinnamic acid 105.52 ± 0.01
Total phenolic acids 724 ± 12
Values expressed as arithmetic mean ± standard deviation (dry basis;
n = 3).
Table 3 Chemical composition of the lipophilic extract (fatty acids and
tocopherols) of Lentinus crinitus basidiocarp
Compound Value (%)
Caproic acid (C6:0) 0.116 ± 0.005
Caprylic acid (C8:0) 0.143 ± 0.001
Capric acid (C10:0) 0.205 ± 0.004
Lauric acid (C12:0) 0.39 ± 0.01
Myristic acid (C14:0) 1.05 ± 0.03
Pentadecanoic acid (C15:0) 1.27 ± 0.01
Palmitic acid (C16:0) 11.23 ± 0.03
Palmitoleic acid (C16:1) 0.32 ± 0.02
Heptadecanoic acid (C17:0) 0.65 ± 0.05
Stearic acid (C18:0) 2.38 ± 0.02
Oleic acid (C18:1n-9) 9.8 ± 0.1
Linoleic acid (C18:2n-6) 66.4 ± 0.3
α-Linolenic acid (C18:3n-3) 1.80 ± 0.01
Arachidic acid (C20:0) 0.253 ± 0.004
Eicosenoic acid (C20:1) 0.072 ± 0.001
cis-11,14-Eicosadienoic acid (C20:2) 0.46 ± 0.01
cis-11,14,17-Eicosatrienoic acid and heneicosanoic acid
(C20:3n-3 + C21:0)
0.55 ± 0.02
Behenic acid (C22:0) 2.3 ± 0.2
Erucic acid (C22:1n-9) 0.082 ± 0.005
Lignoceric acid (C24:0) 0.52 ± 0.01
Total saturated fatty acids (% of total fatty acids) 20.5 ± 0.2
Total monounsaturated fatty acids (% of total fatty
acids)
10.29 ± 0.09
Total polyunsaturated fatty acids (% of total fatty acids) 69.2 ± 0.3
Tocopherol
β-Tocopherol (µg per 100 g) 505 ± 32
Values expressed as arithmetic mean ± standard deviation (dry basis;
n = 3); cis-11,14,17-eicosatrienoic and heneicosanoic acids had a single
combined value because the chromatographic system does not allow
the separation of these compounds.
Table 4 Cytotoxic activity of the methanolic extracts of Lentinus crini-
tus basidiocarp and positive control ellipticine against human tumor cell
lines and non-tumor cells
Cell line Basidiocarp (GI50 µg mL
−1) Ellipticine (GI50 µg mL
−1)
Tumor cell
HepG2 >400 3.2 ± 0.5
MCF7 >400 0.91 ± 0.04
NCI-H460 >400 1.42 ± 0.01
HeLa >400 1.1 ± 0.2
Non-tumor cell
PLP2 >400 2.06 ± 0.03
Values expressed as arithmetic mean ± standard deviation (dry basis;
n = 3). GI50 = extract concentration corresponding to 50% growth inhi-
bition activity. MCF-7 = breast adenocarcinoma, NCI-H460 = lung carci-
noma, HeLa = cervical carcinoma, HepG2 = hepatocellular carcinoma,
and PLP2 = primary cell culture obtained from porcine liver.
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control (Fig. 1). Regarding the ampicillin and streptomycin
controls, the basidiocarp extract had similar or lower MIC
values, except for B. cereus, E. coli, M. luteus, and S. aureus
which showed higher values, and for P. aeruginosa and
E. cloacae whose values were higher than that of streptomycin
control (Fig. 1). These results suggest that the basidiocarp
extract is a promising agent to control almost all the tested
bacteria with higher activity than the controls.
Noticeably, compared to all controls, the basidiocarp
extract was better against L. monocytogenes, P. aeruginosa, and
S. enterica. Moreover, for these strains, the basidiocarp extract
had an MIC varying from 2.7 to 4.0-fold lower than the ampi-
cillin control, and an MIC varying from 2.5 to 10-fold lower
than the food additive controls.
The basidiocarp extract of L. crinitus presented bactericide
activity against all evaluated bacterial strains (Fig. 2). The most
evident strain inhibition of the basidiocarp extract was against
E. coli, L. monocytogenes, M. luteus, P. aeruginosa, S. enterica,
and S. aureus with the lower MBC values compared to food
additive controls (Fig. 2). The MBC values for the basidiocarp
extract ranged from 0.248 to 0.604 mg mL−1, and for the posi-
tive controls they ranged from 0.102 to 0.50 mg mL−1 for strep-
tomycin and from 0.402 to 1.203 mg mL−1 for ampicillin.
Regarding the food additives, the MBC values ranged from
0.497 to 4.04 mg mL−1 for E221, and from 0.502 to 2.02 mg
mL−1 for E224 (Fig. 2). The basidiocarp extract MBC values
were all equal to or lower than those of the food additive con-
trols (Fig. 2). Only for B. cereus the basidiocarp extract revealed
equal values for E221 control, and for E. cloacae higher values
compared to those of E224 control (Fig. 2). The basidiocarp
extract presented lower MBC values against L. monocytogenes
and S. enterica (around 0.25 mg mL−1 for both), values 2.0 and
3.0-fold lower than that for the control ampicillin, respectively,
and 4 to 8-fold lower than that for the food additive controls
(Fig. 2). In addition, MBC values were close to the ones for the
controls against M. luteus and P. aeruginosa (Fig. 2). Once
again, the results obtained suggest that the basidiocarp extract
is a promising agent for controlling most of the studied bac-
teria. Noticeably, when compared to all controls, the basidio-
carp extract was better against L. monocytogenes, and S. enterica
compared with all bacterial strains and controls (Fig. 2). The
basidiocarp extract showed bactericidal activity against the
other remaining bacteria, but with MBC values, in general,
lower than those of the food additive controls and similar to
those of the streptomycin and ampicillin controls (Fig. 2).
The basidiocarp extract was effective against all fungal
strains showing MIC values ranging from 0.0399 to 0.499 mg
mL−1, and for the positive controls the MIC values ranged
from 0.0999 to 0.199 mg mL−1 for bifonazole, and from 0.200
to 2.499 mg mL−1 for ketoconazole. Regarding food additives,
MIC values ranged from 1.01 to 2.03 mg mL−1 for E211, and
from 0.500 to 2.01 mg mL−1 for E224 (Fig. 3). The basidiocarp
extract had lower MIC values for all fungal strains compared to
food additive controls (Fig. 3). For the positive controls ampi-
cillin and streptomycin, the basidiocarp extract presented MIC
values that were equal to or lower than the ones for the fungal
strains, except against A. fumigatus and A. versicolor, for which
it had higher values (Fig. 3).
The MFC of the basidiocarp extract was effective against all
fungal strains and ranged from 0.0601 to 0.6004 mg mL−1, and
for the positive controls it ranged from 0.198 to 0.2504 mg
mL−1 for bifonazole, and from 0.302 to 3.49 mg mL−1 for keto-
conazole. Regarding food additives, the MFC ranged from 2.01
to 4.04 mg mL−1 for E211, and from 0.502 to 2.02 mg mL−1 for
Fig. 1 Minimum inhibitory concentration (MIC) of Lentinus crinitus
basidiocarp extract and positive controls streptomycin, ampicillin,
sodium sulfite (E221), and potassium metabisulfite (E224). Different
letters indicate significant differences among treatments and controls
by Tukey’s HSD (honestly significant difference) test (p < 0.05) (arith-
metic mean ± standard deviation; n = 3).
Fig. 2 Minimum bactericidal concentration (MBC) of Lentinus crinitus
basidiocarp extract and positive controls streptomycin, ampicillin,
sodium sulfite (E221), and potassium metabisulfite (E224). Different
letters indicate significant differences among treatments and controls
by Tukey’s HSD (honestly significant difference) test (p < 0.05) (arith-
metic mean ± standard deviation; n = 3).
Fig. 3 Minimum inhibitory concentration (MIC) of Lentinus crinitus
basidiocarp extract and positive controls bifonazole, ketoconazole,
sodium sulfite (E221), and potassium metabisulfite (E224). Different
letters indicate significant differences among treatments and controls
by Tukey’s HSD (honestly significant difference) test (p < 0.05) (arith-
metic mean ± standard deviation; n = 3).
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E224 (Fig. 4). The MFC values of the basidiocarp extract were
all lower than those of the food additive controls. The basidio-
carp extract presented lower MFC values against A. ochraceus,
P. ochrochlorum, and T. viride when compared to all controls.
For A. niger and P. funiculosum, the basidiocarp extract MFC
values did not differ from that of bifonazole control and were
only 2.0-fold lower than that of ketoconazole control. However,
the values were lower for both fungal strains when compared
to food additive controls, which indicates the high efficiency of
the basidiocarp extract. For A. versicolor and A. fumigatus, MFC
values of basidiocarp extract were higher than those of bifona-
zole and ketoconazole controls but still lower than those of
E221 and E224 controls.
Overall, the basidiocarp extract presented bacteriostatic and
bactericide activity against all the studied bacteria with better
MIC and MBC values than most controls (Fig. 1 and 2), and
also fungistatic and fungicide activity against all the fungi
tested, with better MIC and MFC values than most controls
(Fig. 3 and 4). Therefore, the L. crinitus basidiocarp extract has
potential utilization for controlling important microorganisms
in food and health.
4. Discussion
Edible mushrooms have good nutritional quality, especially
proteins, fibers, and also bioactive compounds like
polyphenols.46,47 Our study showed that L. crinitus basidiocarp
is a good source of carbohydrates and proteins, having a low-
fat content, as reported for other mushrooms.3,47,47 Thus, as
all these studies suggest, mushrooms are a good option for
inclusion in low-calorie diets.49
The protein content values of L. crinitus basidiocarp
reported in previous studies was 9.8 g per 100 g (original value
converted by 4.38 factor),17 10.1 g per 100 g (original value con-
verted by 4.38 factor),18 and 27.0 g per 100 g.16 Our results
showed that the protein content (13.0 g per 100 g) is similar to
those found in the literature for this fungus. Chang and
Miles50 reported that edible mushrooms normally contain 19.0
to 35.0 g per 100 g protein (dry basis) and Kalač3 reported that
that of wild-growing mushrooms ranged from 13.2 to 62.8 g
per 100 g. Therefore, we can conclude that the values obtained
for the protein content of L. crinitus are slightly below the
range reported in the literature for this type of food. However,
compared to other foods, the protein levels of this mushroom
are similar to the levels found in eggs (13.0 g per 100 g) and
are even higher than those found in raw rice (7.3 g per 100 g)
or wheat flour (9.8 g per 100 g).51
Trehalose is the main oligosaccharide in mushrooms
ranging from 0.21 to 42.8 g per 100 g with the median from
3.8 to 4.0 g per 100 g for wild collected mushrooms,3,52 and
from 0.23 to 72.8 g per 100 g with a median of 2.63 g per 100 g
for commercial cultivated mushrooms.3 For L. crinitus basidio-
carp, in our study, trehalose (3.5 g per 100 g) was the most
abundant soluble sugar and it had a similar content compared
to most basidiomycetes reported in the literature. Trehalose
has effects on metabolic pathways such as modulating glucose
homeostasis, improving beta cell function, reducing postpran-
dial insulin release, and lipid profile.53–55 In addition, treha-
lose migrates from mycelia to basidiocarps and protects the
cells against stresses such as desiccation, temperature, and
oxygen pressures.56,57 This oligosaccharide may also be related
to L. crinitus enzymatic activity29 and mycelial biomass pro-
duction, mainly at extreme temperatures (19 to 40 °C) and pH
(2.5 to 10) conditions.58
Edible mushroom fat contents were reported from 1.1 to
8.3 g per 100 g.50 For L. crinitus basidiocarp cultivated in a sub-
strate based on Theobroma grandiflorum exocarp, the fat
content ranged from 3.3 to 4.5 g per 100 g (ref. 16) and was
1.5 g per 100 g for wild L. crinitus basidiocarp collected in the
Brazilian Cerrado.17 In our study, the basidiocarp had a lower
fat content (0.48 g per 100 g) compared with wild and culti-
vated L. crinitus basidiocarp or other mushrooms. Moreover,
the L. crinitus basidiocarp from our study had the lowest value
of total monounsaturated fatty acids (10.3% of total fatty acids)
and the highest value of total polyunsaturated fatty acids
(69.2% of total fatty acids), the major compound being linoleic
acid (C18:2n-6) followed by oleic acid (C18:1n-9) and α-linolenic
acid (C18:3n-3). Oleic acid (omega-9) may reduce the risk of cor-
onary artery diseases.59 Linoleic acid (omega-6), considered an
essential fatty acid that cannot be synthesized by the human
body, is a precursor of arachidonic acid which plays an impor-
tant role in inflammatory processes,60 and has a significant
role in health because it lowers cholesterol and triglycerides.61
α-Linolenic acid is also an essential fatty acid which showed
physiological benefits in humans such as brain development,
anti-inflammatory activity, and cardiovascular health
improvement.62–65
Tocopherols are known natural antioxidant compounds66
with anti-inflammatory and anticancer properties with peroxi-
dation prevention in cellular membrane phospholipids.67 In
our study, β-tocopherol (505 µg per 100 g) was the only vitamin
identified. The majority of mushrooms (seven out of eight)
studied by Barros et al.49 had lower levels of β-tocopherol (3 to
193 µg per 100 g) than L. crinitus; only one (Boletus edulis) had
a higher β-tocopherol content (890 µg per 100 g). Toledo
Fig. 4 Minimum fungicidal concentration (MFC) of Lentinus crinitus
basidiocarp extract and positive controls bifonazole, ketoconazole,
sodium sulfite (E221), and potassium metabisulfite (E224). Different
letters indicate significant differences among treatments and controls
by Tukey’s HSD (honestly significant difference) test (p < 0.05) (arith-
metic mean ± standard deviation; n = 3).
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et al.52 reported that among nine wild mushrooms, four had
12.36 to 59.03 µg per 100 g β-tocopherol but it was not detect-
able in five mushroom species. Wild mushrooms (fourteen out
of eighteen) studied by Heleno et al.37 had lower levels of
β-tocopherol (7 to 386 µg per 100 g), only one (Laccaria laccata)
showed higher levels (706 µg per 100 g) than L. crinitus, but it
was not detected in three species. This suggests that L. crinitus
basidiocarp has high β-tocopherol levels compared with the
average values reported in the literature.
For hydrophilic compounds, malic acid has been reported
with values of 130 mg per 100 g for Agaricus bisporus and is
absent for Agaricus brasiliensis.48 Oxalic acid, another hydro-
philic compound, has been reported with values of 580 mg per
100 g for A. bisporus48 and 115 mg per 100 g for A. brasiliensis.68
This indicates that the values for malic (730 mg per 100 g) and
oxalic (132 mg per 100 g) acids of our study are among the
highest reported levels. These organic acids have a considerable
effect on the taste and acceptability of mushrooms and can play
a biological role in health due to their potential antioxidant
activity.68 In addition, oxalic acid has antibacterial activity.69
Phenolic compounds are one of the most important groups
of secondary metabolites found in mushrooms66 that exhibit
antioxidant capacity and provide protection against disorders
with anticancer, cardioprotective, anti-inflammatory, antith-
rombotic, and vasodilator activities.66,70–72 The main phenolic
acid found in our study was p-hydroxybenzoic acid (724 µg per
100 g). Other studies reported values of 10, 156, and 157 µg
per 100 g for commercial mushrooms such as Pleurotus eryngii,
Pleurotus ostreatus, and Lentinula edodes,73 respectively, and
from 469 to 2407 µg per 100 g (mean of 1304 µg per 100 g) for
eight edible commercial mushrooms,46 and from 0 µg to
23 870 µg per 100 g (mean of 3358 µg per 100 g) for wild mush-
rooms,74 but it was not found for A. bisporus commercial
mushroom.73 This indicates that the p-hydroxybenzoic acid
value found in L. crinitus basidiocarp in our study had an
intermediary value among the ones reported in the literature.
Since the bioactivities (e.g. antioxidant and antimicrobial
activity) of organic acids and specifically phenolic compounds
are related to the response to stress conditions (abiotic, eda-
phoclimatic, or production conditions),75 this may justify the
greater or lesser differences among values for different species,
as well as the absence of any compound.
The antimicrobial activity of the L. crinitus basidiocarp
extract was verified against all the studied bacterial and fungal
strains, showing a broad action spectrum. The antibacterial
activity of P. ostreatus and L. edodes basidiocarp extracts has
been reported against S. aureus, B. subtilis, E. coli,
P. aeruginosa, and S. enterica with MIC values varying from 2.0
to 8.0 mg mL−1.76 Methanolic extracts of A. brasiliensis and
A. bisporus were tested against the same bacterial strains used
in our study, revealing MIC values ranging from 0.1 to 2.30 mg
mL−1 and 0.3 to 1.15 mg mL−1, respectively, and MBC values
ranging from 0.3 to 4.60 mg mL−1 and from 0.3 to 4.70 mg
mL−1, respectively.48 P. ostreatus, L. edodes, and A. bisporus
were tested against E. coli and P. aeruginosa showing MIC
values higher than 20 mg mL−1;77 and L. edodes was tested
against B. cereus, S. aureus, and E. coli revealing MIC values
ranging from 1.56 to 100 mg mL−1.78 Our results for the
L. crinitus basidiocarp extract presented MIC values ranging from
13 to 200-fold higher activity than the values reported in the lit-
erature for the same bacteria with bacteriostatic activity. In
addition, this extract presented MBC values ranging from 2.0 and
9.0-fold higher activity than the values reported in the literature
for the same bacteria with bactericidal activity. On the other
hand, for the A. brasiliensis ethanolic extract, the most sensitive
bacteria were S. aureus and B. cereus with MIC values of 0.08 and
0.04 mg mL−1 and MBC of 0.20 and 0.08 mg mL−1, respectively,48
showing higher activity than those in our studies (MIC 0.40 and
MBC 0.50 mg mL−1) for both species, respectively. However, in
our study L. crinitus showed antibacterial activity with MIC and
MBC values, respectively, ranging from 4.2 to 9.5 and 2.0 to 6.7-
fold lower than those of the food additive controls and similar to
some antibiotic controls, and the mushroom extract has stronger
bacteriostatic and bactericidal activities than streptomycin and
ampicillin against L. monocytogenes and S. enterica.
The antifungal activity of P. ostreatus basidiocarp extracts
expressed as the MIC value has been reported as 12 mg mL−1
against A. niger and 16 mg mL−1 against P. funiculosum, but no
activity was observed against A. fumigatus and T. viride.79 The
extract of A. brasiliensis basidiocarp presented an MIC of
0.15 mg mL−1 and MFC of 1.15 mg mL−1 against
A. versicolor,48 and the 1 mg mL−1 hydroalcoholic extract of
L. crinitus basidiocarp presented 50% mycelial growth inhi-
bition of Fusarium sp. conidia.19 Ganoderma lucidum against
the same fungal strains used in our study revealed MIC values
from 0.005 to 1.5 mg mL−1 and MFC from 0.1 to 4.5 mg
mL−1.80 The basidiocarp extract of L. crinitus, in our study, had
MIC values 3.7 to 8.8-fold lower than that of G. lucidum extract
for the same fungal strains,80 and for A. versicolor, T. viride,
and P. funiculosum had 15 and 19-fold lower values of MIC and
MFC than those for L. crinitus. Moreover, L. crinitus had,
respectively, MIC and MFC values 2.5 to 25.2- and 3.4 to 33.6-
fold lower than the ones of food additive and antibiotic con-
trols evaluated in our study. In addition, L. crinitus was more
effective than bifonazole and ketoconazole against
A. ochraceus, P. ochrochloron, and T. viride. Thus, our results
make evident the antifungal potential of L. crinitus, which pre-
sents a broad action spectrum against infectious fungi and
mainly foodborne diseases related to fungi in food.
The antimicrobial activity of basidiomycetes may be related
to several chemical compounds such as terpenes, organic
acids, phenolic compounds, and steroids among others.8,80–83
The acids p-hydroxybenzoic and cinnamic had MIC values
from 0.003 to 0.12 mg mL−1 and from 0.007 to 0.03 mg mL−1,
respectively, against A. fumigatus, A. versicolor, A. ochraceus,
A. niger, T. viride, P. funiculosum, P. ochrochloron, and
P. verrucosum.80 In addition, p-hydroxybenzoic acid has been
indicated as an antimicrobial agent against bacteria and
fungi.84 Other compounds such as malic and oxalic acids are
food safety additives85 and have been reported as having anti-
microbial activity. Malic acid was reported with antimicrobial
activity against E. coli, L. monocytogenes,86,87 Salmonella enteri-
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tidis,86 and Salmonella gaminara.87 Oxalic acid was reported
with antimicrobial activity against E. coli.88 In our study,
L. crinitus showed several major bioactive compounds such as
p-hydroxybenzoic, cinnamic, β-tocopherol, linoleic, malic, and
oxalic acids that may still be acting synergistically toward anti-
microbial activity. The antimicrobial activity might be related
to the ability of linoleic acid to break bacterial cell mem-
branes;89 the phenolic acid compounds to destabilize the bac-
terium cytoplasmic membrane, altering the plasma per-
meability and inhibiting extracellular microbial enzymes;90
and the non-dissociated form of organic acid penetration into
cells ensuing cytoplasm acidification.91
Our study suggests that L. crinitus basidiocarp – a mush-
room mainly consumed by Amazonian ethnic groups9 – pre-
sents nutritional and nutraceutical compounds, high anti-
microbial activity, and no cytotoxicity, which makes it a poten-
tial candidate for mushroom industrial production.
5. Conclusions
L. crinitus basidiocarp has considerably high levels of carbo-
hydrates, energy, soluble sugars, β-tocopherol, phenolic acids
(mainly p-hydroxybenzoic acid), and organic acids (mainly malic
and oxalic acids). The predominant lipophilic compounds are
polyunsaturated fatty acids, mainly linoleic (66.4%), palmitic
(11.2%), and oleic (9.8%) acids. The basidiocarp extract has no
cytotoxic activity against human tumor cell lines HeLa, HepG2,
MCF-7, and NCI-H460, as well as against PLP2 non-tumor cells.
The basidiocarp extract has bacteriostatic, bactericidal, fungi-
static, and fungicidal activities against all tested microorganisms
with MBC and MFC values similar or in several cases signifi-
cantly lower to those found in commercial antibiotics, and much
lower than those found in commercial food additives. Most bac-
tericidal activity is against L. monocytogenes and S. enterica while
the fungicidal activity is mostly against P. ochrochloron, followed
by A. ochraceus and T. viride. This study promotes the consump-
tion of L. crinitus basidiocarp that is without toxicity. Its nutri-
tional and bioactive potential has been established and com-
pared with other edible and medicinal mushrooms. Therefore,
its consumption, which is mostly made by indigenous popu-
lations, can be extended. Moreover, the basidiocarp extract of
L. crinitus and its compounds emerge as a potential alternative to
the available antimicrobials, having a broad action spectrum.
However, the antimicrobial mechanism of action of L. crinitus
extract needs to be elucidated along with the compounds respon-
sible for the antimicrobial activity against the tested microorgan-
isms. These results contribute to the development of new studies
in which this species may be at the base of the development of
new antimicrobial formulations for application in the food,
pharmaceutical, and/or agriculture industries.
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